Are there differences in efficacy and safety between local and imported direct-acting antiviral agents for hepatitis C in China?

Abstract Background Despite price advantages, local direct-acting antiviral agents (DAAs) for hepatitis C (hep C) have not been widely used in China compared with the imported ones. There is no evidence on their relative efficacy and safety, nor whether the small market share of local DAAs was attri...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Zhitao Wang, Youbing Ran, Yihan Fu, Jing Sun, Yuanli Liu
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2025-07-01
Reeks:	Infectious Diseases of Poverty
Onderwerpen:	Direct-acting antiviral agent Hepatitis C Hepatitis C virus Efficacy Safety
Online toegang:	https://doi.org/10.1186/s40249-025-01344-2
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!